Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8K Sell
300
-2,110
-88% -$19.6K ﹤0.01% 1026
2026
Q1
$24.1K Buy
2,410
+600
+33% +$6.24K ﹤0.01% 822
2025
Q4
$18.3K Hold
1,810
﹤0.01% 849
2025
Q3
$16.2K Hold
1,810
﹤0.01% 864
2025
Q2
$18.8K Hold
1,810
﹤0.01% 795
2025
Q1
$18.6K Hold
1,810
﹤0.01% 801
2024
Q4
$17.3K Hold
1,810
﹤0.01% 794
2024
Q3
$19.1K Hold
1,810
﹤0.01% 774
2024
Q2
$15K Hold
1,810
﹤0.01% 796
2024
Q1
$15.4K Hold
1,810
﹤0.01% 778
2023
Q4
$14.9K Sell
1,810
-450
-20% -$3.71K ﹤0.01% 779
2023
Q3
$18.8K Buy
2,260
+440
+24% +$3.66K ﹤0.01% 743
2023
Q2
$15.3K Sell
1,820
-800
-31% -$6.83K ﹤0.01% 759
2023
Q1
$21.3K Sell
2,620
-217
-8% -$1.73K ﹤0.01% 704
2022
Q4
$22.7K Sell
2,837
-625
-18% -$4.25K ﹤0.01% 660
2022
Q3
$21K Buy
+3,462
New +$22.4K ﹤0.01% 692

Other funds holding HLN

HM Payson & Co's HLN Position: Q2 2026 in Review

HM Payson & Co reduced its Haleon (HLN) stake by 88% in Q2 2026, selling an estimated $19.6K and leaving 300 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

HM Payson & Co first reported a position in HLN in Q3 2022 and has held it in 16 quarters since. The position peaked at $24.1K in Q1 2026. 641 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • HM Payson & Co held 300 shares of Haleon worth $2.8K as of Q2 2026.
  • HM Payson & Co sold 2,110 Haleon shares in Q2 2026, an estimated $19.6K.
  • Haleon made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1026 holding.
  • HM Payson & Co first reported a position in Haleon in Q3 2022 and has held it in 16 quarters since.
  • HM Payson & Co's Haleon position peaked at $24.1K in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.